| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota 55455-0315 [L. W. W., R. D. E.]; Graduate Studies in Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455 [T. S. W., C. L. Z.]; and National Cancer Institute, Bethesda, Maryland 20892 [V. E. S., G. J. K.]
This investigation is part of a continuing effort to develop effective chemoprevention for carcinogenesis of the lung. The present study explores the use of aerosol administrations for this purpose. The agent selected for initial study was the synthetic glucocorticoid budesonide. This selection was based on previous work in which budesonide added to the diet was found to inhibit pulmonary adenoma formation in female A/J mice. However, high dose levels were required, i.e., of the order of 300 µg/kg, of body weight [L. W. Wattenberg and R. D. Estensen, Carcinogenesis (Lond.), 18: 2015–2017, 1997]. For aerosol administration of budesonide, a nose-only technique has been developed that entails nebulization of the compound dissolved in ethanol and subsequent stripping off of the solvent (less than 3 µl ethanol/liter of air remaining at the site of inhalation). The budesonide particles produced by the apparatus had a mass median aerodynamic diameter of less than 1 µm. An experiment has been carried out in which the inhibitory effects of aerosolized budesonide, given for 1 min six times a week, were studied. Concentrations of budesonide of 26, 81, and 148 µg/liter of air (calculated doses of 23, 72, and 126 µg/kg of body weight) were used. The aerosols were started 1 week after three oral administrations of benzo(a)pyrene (2 mg/20 g of body weight) to female A/J mice. All three doses of budesonide resulted in more than 80% inhibition of pulmonary tumor formation compared to the aerosol control and 90% or greater compared to mice not exposed to aerosol. The difference in inhibition is due to the aerosol procedure itself, which produces a reduction in tumor formation. A decrease in splenic weight (evidence of a systemic effect) occurred at all doses of budesonide. To the best of our knowledge, this is the first published effort at the use of aerosol administration to prevent neoplasia of the respiratory tract. The results of the present study show that administration of a potential chemopreventive agent by aerosol at a low dose can inhibit the occurrence of pulmonary carcinogenesis in female A/J mice.
1 This work was supported by National Cancer Institute Contract No. N01-CN-55177.
2 These authors contributed equally to this work. (L. W. W., animal prevention studies; T. S. W., aerosol technology).
3 To whom requests for reprints should be addressed, at Department of Laboratory Medicine and Pathology, University of Minnesota, 6-133 Jackson Hall, 321 Church Street, SE, Minneapolis, MN 55455-0315.
Received 10/21/97. Accepted 11/ 7/97.
This article has been cited by other articles:
![]() |
D. D. Sin, S. F. P. Man, A. McWilliams, and S. Lam Surfactant Protein D and Bronchial Dysplasia in Smokers at High Risk of Lung Cancer Chest, September 1, 2008; 134(3): 582 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kopelovich, J. R. Fay, C. C. Sigman, and J. A. Crowell The Mammalian Target of Rapamycin Pathway as a Potential Target for Cancer Chemoprevention Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1330 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, L. Tao, R. A. Lubet, V. E. Steele, and M. A. Pereira Modulation by budesonide of a CpG endonuclease in mouse lung tumors Carcinogenesis, July 1, 2007; 28(7): 1499 - 1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.B. Myrdal, K. Karlage, P.J. Kuehl, B.S. Angersbach, B.A. Merrill, and P.D. Wightman Effects of novel 5-lipoxygenase inhibitors on the incidence of pulmonary adenomas in the A/J murine model when administered via nose-only inhalation Carcinogenesis, May 1, 2007; 28(5): 957 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. E. Miller and R. L. Keith Inhaled Corticosteroids and Lung Cancer Chemoprevention Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 636 - 637. [Full Text] [PDF] |
||||
![]() |
T. Parimon, J. W. Chien, C. L. Bryson, M. B. McDonell, E. M. Udris, and D. H. Au Inhaled Corticosteroids and Risk of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 712 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Alyaqoub, L. Tao, P. M. Kramer, V. E. Steele, R. A. Lubet, W. T. Gunning, and M. A. Pereira Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (ZarnestraMT) Carcinogenesis, January 1, 2007; 28(1): 124 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Alyaqoub, L. Tao, P. M. Kramer, V. E. Steele, R. A. Lubet, W. T. Gunning, and M. A. Pereira Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (ZarnestraMT) Carcinogenesis, December 1, 2006; 27(12): 2442 - 2447. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Balansky, F. D'Agostini, G. Ganchev, A. Izzotti, B. Di Marco, R. A. Lubet, N. Zanesi, C. M. Croce, and S. De Flora Influence of FHIT on benzo[a]pyrene-induced tumors and alopecia in mice: Chemoprevention by budesonide and N-acetylcysteine PNAS, May 16, 2006; 103(20): 7823 - 7828. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Sin, S. F. P. Man, A. McWilliams, and S. Lam Progression of Airway Dysplasia and C-Reactive Protein in Smokers at High Risk of Lung Cancer Am. J. Respir. Crit. Care Med., March 1, 2006; 173(5): 535 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Bauer, A. M. Malkinson, and S. R. Kleeberger Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L685 - L703. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lam, J. C. leRiche, A. McWilliams, C. MacAulay, Y. Dyachkova, E. Szabo, J. Mayo, R. Schellenberg, A. Coldman, E. Hawk, et al. A Randomized Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) in People with Dysplasia of the Bronchial Epithelium Clin. Cancer Res., October 1, 2004; 10(19): 6502 - 6511. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Lubet, Z. Zhang, Y. Wang, and M. You Chemoprevention of Lung Cancer in Transgenic Mice Chest, May 1, 2004; 125(5_suppl): 144S - 147S. [Full Text] [PDF] |
||||
![]() |
L. W. Wattenberg, T. S. Wiedmann, and R. D. Estensen Chemoprevention of Cancer of the Upper Respiratory Tract of the Syrian Golden Hamster by Aerosol Administration of Difluoromethylornithine and 5-Fluorouracil Cancer Res., April 1, 2004; 64(7): 2347 - 2349. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Estensen, M. M. Jordan, T. S. Wiedmann, A. R. Galbraith, V. E. Steele, and L. W. Wattenberg Effect of chemopreventive agents on separate stages of progression of benzo[{alpha}]pyrene induced lung tumors in A/J mice Carcinogenesis, February 1, 2004; 25(2): 197 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Prindiville, T. Byers, F. R. Hirsch, W. A. Franklin, Y. E. Miller, K. O. Vu, H. J. Wolf, A. E. Baron, K. R. Shroyer, C. Zeng, et al. Sputum Cytological Atypia as a Predictor of Incident Lung Cancer in a Cohort of Heavy Smokers with Airflow Obstruction Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 987 - 993. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, Z. Zhang, E. Kastens, R. A. Lubet, and M. You Mice with Alterations in Both p53 and Ink4a/Arf Display a Striking Increase in Lung Tumor Multiplicity and Progression: Differential Chemopreventive Effect of Budesonide in Wild-type and Mutant A/J Mice Cancer Res., August 1, 2003; 63(15): 4389 - 4395. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Dragnev, D. Stover, and E. Dmitrovsky Lung Cancer Prevention: The Guidelines Chest, January 1, 2003; 123(1_suppl): 60S - 71S. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Kisley, B. S. Barrett, A. K. Bauer, L. D. Dwyer-Nield, B. Barthel, A. M. Meyer, D. C. Thompson, and A. M. Malkinson Genetic Ablation of Inducible Nitric Oxide Synthase Decreases Mouse Lung Tumorigenesis Cancer Res., December 1, 2002; 62(23): 6850 - 6856. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Kisley, B. S. Barrett, L. D. Dwyer-Nield, A. K. Bauer, D. C. Thompson, and A. M. Malkinson Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice Carcinogenesis, October 1, 2002; 23(10): 1653 - 1660. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Greenberg, J. Hu, S. Basu, J. Hay, J. Reibman, T.-a. Yie, K. M. Tchou-Wong, W. N. Rom, and T. C. Lee Glucocorticoids Inhibit Lung Cancer Cell Growth through Both the Extracellular Signal-Related Kinase Pathway and Cell Cycle Regulators Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 320 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Pereira, Y. Li, W. T. Gunning, P. M. Kramer, F. Al-Yaqoub, R. A. Lubet, V. E. Steele, E. Szabo, and L. Tao Prevention of mouse lung tumors by budesonide and its modulation of biomarkers Carcinogenesis, July 1, 2002; 23(7): 1185 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Malkinson, R. A. Radcliffe, and A. K. Bauer Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice Carcinogenesis, March 1, 2002; 23(3): 411 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Witschi, I. Espiritu, M. Suffia, and K. E. Pinkerton Expression of cyclin D1/2 in the lungs of strain A/J mice fed chemopreventive agents Carcinogenesis, February 1, 2002; 23(2): 289 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. O'Shaughnessy, G. J. Kelloff, G. B. Gordon, A. J. Dannenberg, W. K. Hong, C. J. Fabian, C. C. Sigman, M. M. Bertagnolli, S. P. Stratton, S. Lam, et al. Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia Clin. Cancer Res., February 1, 2002; 8(2): 314 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lippman and M. R. Spitz Lung Cancer Chemoprevention: An Integrated Approach J. Clin. Oncol., September 15, 2001; 19(90001): 74s - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Dahl, I. M. Grossi, D. P. Houchens, L. J. Scovell, M. E. Placke, A. R. Imondi, G. D. Stoner, L. M. De Luca, D. Wang, and J. L. Mulshine Inhaled Isotretinoin (13-cis Retinoic Acid) Is an Effective Lung Cancer Chemopreventive Agent in A/J Mice at Low doses: A Pilot Study Clin. Cancer Res., August 1, 2000; 6(8): 3015 - 3024. [Abstract] [Full Text] |
||||
![]() |
A. K. Bauer, L. D. Dwyer-Nield, and A. M. Malkinson High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors Carcinogenesis, April 1, 2000; 21(4): 543 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.W. Wattenberg, T.S. Wiedmann, R.D. Estensen, C.L. Zimmerman, A.R. Galbraith, V.E. Steele, and G.J. Kelloff Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol Carcinogenesis, February 1, 2000; 21(2): 179 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht Tobacco Smoke Carcinogens and Lung Cancer J Natl Cancer Inst, July 21, 1999; 91(14): 1194 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Steele, C. A. Holmes, E. T. Hawk, L. Kopelovich, R. A. Lubet, J. A. Crowell, C. C. Sigman, and G. J. Kelloff Lipoxygenase Inhibitors as Potential Cancer Chemopreventives Cancer Epidemiol. Biomarkers Prev., May 1, 1999; 8(5): 467 - 483. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |